I'm pretty sure all of us playing biotech have failures
Without getting into the back and forth, I will say that RVNC has yet to play out commercially, although clinically it seems to have played out in the trials just like he thought it would. That story isn't entirely told yet (no position).
ENTA was another of his spectacular failures... oh wait.
Thanks to Roy's 'failures' like EGRX and ENTA, I retired at 55 and my daughter will be graduating from med school debt free. I also have a large position in RVNC, and I expect that it too will be very profitable within a couple of years. Roy doesn't tell anyone to buy or sell; he just shares his insight and it is very much appreciated.
Off Topic- don't forget Dew's long term position in $WFM...turned out to be a nice $AMZN buyout. Nice work, Dew, $WFM had some of the nicest price per sq ft metrics in the sector, probably enticed Bezos He and I had some enjoyable exchanges/debates on that board about their retail/margin/metric challenges $AMZN dealing with some of those challenges even today! Tune into the $WFM board posts if that is still on Ihub.
Dew Diligence could made a bundle, uh 20 fold plus if he as well as anyone shorted all his conjectures of a myriad of drug companies ultimate prospects to avert endpoint failure...Almost no one here seems to short so this binary easier lift has failed to reap the mansion building shorting rewards.
Unmeasured, Dew actually contributed to IHUBER's saving millions in losses, benefiting from his assaults on incomplete or hidden data, as well as sleuthing the grave financial prospects/ challenges each cycle of assumed claims of progress all the derived info coming to investors from PR's actually meant.
News 
Market Data 
Discover 
AI
